Do you feel tired or have a headache when you wake up in the morning? Something might be going wrong while you sleep that you don't know about: obstructive sleep apnea (pronounced app-nee-uh).

Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that ...

A new study supports a link between obstructive sleep apnea and increased risk for Parkinson’s disease and suggests early use ...

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood ...

(Ivanhoe Newswire) --- Obstructive sleep apnea, or OSA, affects nearly a billion ... MD from the UC San Diego School of Medicine. It’s already FDA-approved to manage diabetes and obesity.

Among patients with OSA, sleep surgery vs CPAP therapy or no treatment reduces the risk for motor vehicle accidents.

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...

Per the FDA, the "probable benefits outweigh the probable risks" for approved obstructive sleep apnea patients who aren't benefitting from traditional CPAP therapy. If you're interested in Inspire ...

Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular dysfunction associated with obstructive sleep apnea ...

Early use of continuous positive airway pressure (CPAP) therapy for sleep apnea could help lower Parkinson's risk, a large ...